✦ LIBER ✦

Evolution of viral RNA in a Chinese patient to interferon/ribavirin therapy for hepatitis C

✍ Scribed by Xian-Zi Wen, Zhi-Hai Chen, Ya-Zhi Wei, Jia-Fu Ji

Book ID: 120946707
Publisher: Chinese Anti-Cancer Association
Year: 2012
Tongue: English
Weight: 999 KB
Volume: 24
Category: Article
ISSN: 1000-9604
DOI: 10.1007/s11670-012-0275-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

327 Characterization of full-lenght hepa

327 Characterization of full-lenght hepatitis C viral RNA sequence in patients treated with interferon and ribavirin combination therapy

✍ Masamichi Tanaka; Fumio Imazeki; Osamu Yokosuka; Tatsuo Kanda; Hiromitsu Saisho 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Early hepatitis C viral RNA decline duri

Early hepatitis C viral RNA decline during therapy with interferon α-2B and ribavirin in patients with chronic hepatitis C without sustained response to prior interferon

✍ Min, A.; Jones, J.; Esposito, S.; Lebovics, E.; Klion, F.; Jacobson, I.; Goldman 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Durability of viral response to interfer

Durability of viral response to interferon ribavirin combination in patients with chronic hepatitis C

✍ T. Poynard; J. McHutchison; G. Davis; R. Esteban; J. Albrecht; M. Ling; I. Group 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Genetic variability of hepatitis C virus

Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon–ribavirin therapy

✍ I. Vuillermoz; E. Khattab; E. Sablon; I. Ottevaere; D. Durantel; C. Vieux; C. Tr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

## Abstract Little is known about hepatitis C virus (HCV) breakthrough during antiviral therapy, although it would help in understanding HCV resistance to current antiviral treatments. To analyse the implication of virological factors and the vigour of humoral immune responses in this phenomenon, w

Estimation of early hepatitis C viral cl

Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model

✍ Frank C. Bekkering; Carlos Stalgis; John G. McHutchison; Johannes T. Brouwer; Al 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Evolution of hepatitis C virus NS5A regi

Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy

✍ H. J. Yuan; M. Jain; K. K. Snow; M. Gale Jr; W. M. Lee; the HALT-C Trial Group 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB